Creatine is having a moment as a brain supplement, and most of what you will read about it is wrong in a very specific way. Not fabricated, just selectively told.
Here is the short version before we go deep. The theory behind creatine brain benefits is genuinely good. The brain burns an enormous amount of energy, creatine helps recycle that energy, and supplementation can raise brain creatine levels modestly. But when you follow the human trials all the way through, including the reanalyses and the corrections that rarely make it into supplement marketing, the picture is far more mixed than the headlines suggest. The strongest and most interesting signal shows up when the brain is under stress, especially sleep deprivation. The evidence for a sharper, better remembering brain in a healthy, well rested adult taking 5 grams a day is thin, and the largest trial ever run on that exact question found almost nothing.
I have been following this literature for years, and I think it is one of the most instructive stories in all of supplement science. Not because creatine is a scam. It is not. It is one of the most studied and safest supplements ever sold. The story is instructive because the gap between what the studies found and what people say the studies found is unusually easy to document. So let us document it.
What the Evidence Actually Shows
If you want the state of play in five sentences, here it is.
First, creatine reliably raises muscle creatine, and it raises brain creatine too, but by much less, typically in the range of about 5 to 10 percent in imaging studies rather than the 20 to 40 percent seen in muscle. Second, meta analyses that initially reported memory benefits have been challenged on statistical grounds, and one of them lost its headline finding when the authors redid the math. Third, the European Food Safety Authority reviewed the whole file in 2024 and concluded the evidence was not sufficient to support a cognition claim. Fourth, the largest randomized trial in healthy adults found effects so small they hovered near zero. Fifth, a small but striking pair of studies suggests a single large dose can blunt the cognitive damage of a night without sleep, which is a real finding, but about a dose seven times larger than what almost anyone actually takes.
That is the honest summary. Everything below is the evidence behind it, so you can judge for yourself rather than taking my word or anyone else’s.
Why the Theory Is Genuinely Good
The brain is roughly 2 percent of your body weight and consumes about 20 percent of your energy at rest. That energy arrives as ATP, the molecule cells spend when they do work, and ATP runs out fast under heavy demand. Creatine’s job, in muscle and in neurons alike, is to act as a rapid recharge system. Cells store creatine in a charged form called phosphocreatine, and when ATP runs low, an enzyme called creatine kinase transfers the stored phosphate back onto spent ATP almost instantly. Think of phosphocreatine as a battery bank sitting next to the generator.
This is not speculative biochemistry. Children born with genetic disorders that prevent creatine from being made or transported suffer severe intellectual disability, which is how researchers know the brain depends on creatine to develop normally. That tells us brain creatine matters enormously when it is missing. The open question, and it is the question this entire field turns on, is whether adding more creatine to a brain that already has a normal amount does anything useful.
Supplementation does move the needle on brain levels, at least somewhat. A frequently cited multinuclear imaging study from 2003 gave healthy young men 0.3 grams per kilogram daily for a week and measured increases in brain creatine ratios of roughly 8 to 9 percent using magnetic resonance spectroscopy, a scanning method that measures chemical concentrations in living tissue. Later work in clinical populations found increases at doses as low as 4 grams a day over months. So the ingredient reaches the brain. The uptake is slow and modest, because the brain makes much of its own creatine and guards its chemistry carefully, but it happens.
Good mechanism, measurable delivery. Now for the part the marketing leaves out.
The Memory Finding That Fell Apart Under Reanalysis
For the last few years, the most quoted evidence for creatine and memory has been a pair of meta analyses. A meta analysis pools the results of many trials into one estimate, and it is only as sound as its statistics. Both of these have problems worth understanding.
The first, published by Prokopidis and colleagues in Nutrition Reviews in 2023, pooled ten randomized controlled trials and reported that creatine improved memory in healthy individuals, with the clearest benefit in older adults aged 66 to 76. It was widely covered. What was not widely covered is what happened next. Two researchers, Eckert and Pascher, wrote a letter to the journal pointing out that the analysis had entered multiple memory outcomes from the same participants as if they were independent data points, which double counts people and inflates statistical power. The original authors, to their credit, reran the analysis properly. In the corrected version, the overall memory effect in healthy individuals was no longer statistically significant. The benefit survived only in the older adult subgroup, which rested on a small number of studies.
The second, a 2024 meta analysis by Xu and colleagues in Frontiers in Nutrition, pooled 16 trials with 492 participants aged roughly 21 to 76 and reported significant effects on memory, attention time, and processing speed, with no effect on overall cognitive function or executive function. The memory effect was modest, a standardized mean difference of 0.31, and the authors graded the certainty of that evidence as moderate. Subgroup analyses suggested larger benefits in people with existing illnesses, in adults under 60, and in women. This paper is now the most cited support for creatine brain benefits, and it appears in nearly every article on the topic.
It has the same statistical flaw. A 2026 commentary in Frontiers in Nutrition walked through how the Xu analysis pooled multiple non independent cognitive test results from the same studies, inflating sample sizes just as the earlier memory paper had. The paper also required a corrigendum in February 2025 to fix an error in its attention results. None of this makes the authors bad actors, and none of it proves creatine does nothing. But it means the two pillars holding up the popular memory claim are considerably weaker than their abstracts read.
When a regulator looked at all of this without a commercial stake, the conclusion was blunt. In its 2024 scientific opinion on creatine and cognitive function, the European Food Safety Authority evaluated a proposed health claim, reviewed 21 human intervention studies plus the Xu meta analysis, flagged the double counting problem explicitly, and determined that no conclusions could be drawn from that meta analysis. The panel rejected the claim. That ruling binds food products in the EU, not supplements in the United States, where the FDA does not preapprove structure and function claims at all. But as a neutral reading of the same evidence everyone else is citing, it is hard to dismiss.
The Largest Trial Ever Run Found Almost Nothing
The study that launched creatine’s reputation as a brain supplement was published by Rae and colleagues in 2003. Forty five young vegetarian adults took 5 grams a day for six weeks in a double blind, placebo controlled crossover design, and the creatine phase produced large, highly significant improvements on a working memory test and an abstract reasoning test. It is a genuinely well designed small study, and for twenty years it has been the field’s favorite citation.
Which is exactly why the replication matters so much. In 2023, Sandkühler and colleagues published the largest trial to date on creatine and cognition in BMC Medicine. They deliberately copied the Rae design, 5 grams a day for six weeks, crossover, double blind, preregistered, but with 123 participants, half vegetarian and half omnivore, and the same two primary outcome measures plus eight exploratory tests.
The results were sobering. No statistically significant effect on either primary outcome or on any of the eight exploratory tasks. Their Bayesian analysis, a statistical approach that weighs how strongly the data support an effect rather than just testing for significance, found evidence for a small benefit, with effect sizes of 0.09 on reasoning and 0.17 on working memory. Those are tiny numbers. The authors themselves noted the effects were far more modest than earlier high profile studies suggested. And critically, vegetarians did not benefit more than omnivores. If anything the creatine effect trended smaller in vegetarians.
That last point deserves a paragraph, because the vegetarian claim is everywhere. The logic sounds airtight: vegetarians eat no dietary creatine, so their brains should be lower in it, so they should gain the most from supplementing. The problem is that measured brain creatine in vegetarians looks about the same as in omnivores. The brain synthesizes its own supply and appears to defend it. Muscle creatine is lower in vegetarians, which is why they respond well to creatine in the gym, but the brain is a different organ with different rules. One older study by Benton and Donohoe did find a memory benefit specific to vegetarians, but it ran a large number of cognitive tests, which raises the odds of a false positive, and the Sandkühler team explicitly treated that finding as exploratory. If you are vegetarian and taking creatine for your muscles, that is well supported. Taking it specifically because you expect a bigger brain effect than a meat eater would get is not what the best current evidence shows.
There is also a broader skeptical reading of the whole field worth knowing about. A 2024 systematic review by McMorris and colleagues went through the literature and concluded that the research fails to support the theoretical basis for an effect on cognition, noting that supplementation raises brain creatine only to a limited extent and that the behavioral findings are inconsistent. I think that conclusion is somewhat too harsh, for reasons the next section explains, but any honest article has to tell you it exists.
Where the Signal Is Real: The Stressed Brain
Here is where the story turns, and where I think the most defensible version of creatine brain benefits lives. The energy recharge theory predicts that extra creatine should matter most when the brain’s energy system is under strain. A rested brain has enough phosphocreatine on hand. A sleep deprived brain, running its metabolism hard for 21 straight hours, may not. And that is exactly where the cleanest positive results keep appearing.
In 2024, Gordji-Nejad and colleagues at the Jülich research center in Germany published a remarkable study in Scientific Reports. Fifteen healthy adults, average age 23, stayed awake for 21 hours overnight in a lab, twice, in a double blind crossover design. On one night they swallowed a single enormous dose of creatine monohydrate, 0.35 grams per kilogram of body weight, roughly 25 grams for an average adult. On the other night, placebo. The researchers scanned their brains repeatedly with phosphorus and proton magnetic resonance spectroscopy while running cognitive tests at baseline and at 3, 5.5, and 7.5 hours after the dose.
The creatine night looked measurably different. Brain phosphocreatine and energy markers held up against the decline that sleep deprivation normally causes, participants reported less fatigue, and performance on processing speed and memory tasks was better than on the placebo night, in some measures even better than the rested evening baseline. It was the first evidence that a single oral dose could push creatine into the brain fast enough to matter, apparently because a sleep deprived brain, hungry for energy, temporarily pulls in more creatine than a rested one would.
Small studies with striking results have a habit of shrinking on replication, so the follow up matters. In 2026 the same group published a second sleep deprivation study in Nutrients, again using high single doses, and again reported that creatine blunted the deterioration in logical reasoning, numerical tasks, language related processing speed, and psychomotor vigilance that sleep loss normally produces. Two consistent results from one lab is not the same as an independent replication, and I want to be plain about that. But it is a coherent, mechanistically sensible finding measured with brain imaging, not just questionnaires, and it deserves the attention it is getting.
Now the caveat that this entire site exists to make. That dose was 0.35 grams per kilogram, taken once, under medical supervision. That is about seven times a standard 3 to 5 gram daily serving. Nothing in these studies tells you that your everyday scoop of creatine will rescue you after an all nighter, and nobody should present a single dose lab protocol as evidence for a daily habit. Earlier sleep deprivation studies that used ordinary supplementation schedules, like McMorris in 2006 and Cook in 2011, found some benefits on specific tasks too, but the dramatic 2024 imaging results belong to the high dose protocol and only to it.
Older Adults, Women, and Everyone Hoping for More
After the stressed brain, the second most plausible beneficiary group is older adults, and here the evidence is suggestive but genuinely thin. The corrected Prokopidis analysis retained a memory benefit in adults aged 66 to 76, based on two studies. A 2026 systematic review in Nutrition Reviews focused specifically on aging found a generally positive relationship between creatine and cognition in older adults across six studies, while pointing out that the Xu meta analysis had found, surprisingly, the opposite pattern, with larger benefits in adults under 60. Two reviews, opposite subgroup conclusions, tiny study counts on both sides. That is not a foundation you can build confident claims on. It is a foundation you can build good future trials on, which is different.
The Xu subgroup analyses also flagged women as possibly benefiting more, which has become a popular talking point. It rests on the same double counted dataset as everything else in that paper, so treat it as a hypothesis, not a result. There are decent physiological reasons to study creatine in women specifically, including lower average dietary intake and hormonal effects on creatine metabolism, and dedicated trials are underway. Until they read out, nobody honestly knows.
And for the healthy, rested, omnivorous adult in their twenties or thirties who wants sharper focus at work, the truthful answer is the least satisfying one. The largest and best controlled trial in almost exactly that population found effects statistically indistinguishable from zero on its primary outcomes. If creatine does something for you in that situation, current evidence says it is small.
The Dose Problem Nobody Wants to Talk About
There is a live scientific argument that the field has been testing the wrong doses all along, and it cuts in an interesting direction. The brain absorbs supplemental creatine slowly and reluctantly. Muscle saturates nicely on 3 to 5 grams a day. The brain may need more, for longer. A dose ranging study by Kondo and colleagues, discussed in a 2025 review arguing that more is likely better for brain outcomes, measured frontal lobe phosphocreatine after 2, 4, or 10 grams daily for eight weeks and found increases of 4.6, 4.1, and 9.1 percent respectively. In other words, the brain barely distinguished 2 from 4 grams, and only the 10 gram group roughly doubled the response.
A 2026 review pointedly titled around putting the cart before the horse makes the uncomfortable version of this argument: many of the cognitive trials in this literature never verified that brain creatine actually rose in their participants, which means a null result cannot distinguish between creatine does not help and creatine never arrived. That is a fair criticism of the field, and it means the honest range of possibilities is wider than either the fans or the skeptics usually admit. Standard doses may simply be too small a brain stimulus to test the hypothesis properly.
Notice what this argument is not. It is not evidence that higher doses improve cognition. It is evidence that higher doses raise brain creatine more, plus a plausible case that trials should test them. Whether the extra brain creatine translates into anything you would notice is precisely the unanswered question.
What the Studies Used Versus What People Actually Do
It is worth laying the mismatch out plainly, because this is where most creatine brain content quietly misleads.
What people actually do: take 3 to 5 grams of creatine monohydrate daily, often in coffee or a shake, and hope for better memory and focus within a few weeks. What the encouraging studies actually used: a single 25 gram equivalent dose during enforced sleep deprivation in a scanner, or 20 grams a day in small clinical pilot studies, or 5 grams a day in a small 2003 vegetarian study whose large scale replication came back essentially empty. The trial that most closely matches real world use, Sandkühler’s 5 grams a day for six weeks in ordinary healthy adults, is the one with the near null result. The EFSA file also included a trial by Moriarty and colleagues in 2023 that gave healthy young adults 10 or even 20 grams a day for six weeks and still found no effect on processing speed, episodic memory, or executive function.
None of this means daily creatine is pointless. The muscle and strength evidence is about as solid as sports nutrition gets, and there are worse reasons to take a supplement than well established physical benefits with a possible cognitive upside in hard weeks. It means the cognitive upside, as tested at real world doses in rested healthy people, has not shown up convincingly yet.
Safety, Briefly and Honestly
Creatine monohydrate has one of the deepest safety records in the supplement world. The International Society of Sports Nutrition position stand reviewed decades of data and reported no meaningful harm to kidney function in healthy people at doses up to 10 grams a day for years, including one cited cohort using up to 10 grams daily for as long as five years, and up to 30 grams a day in shorter clinical contexts. The most common effects are a bit of water weight and, at larger single doses, stomach upset. One practical note: creatine raises blood creatinine, a routine kidney lab marker, without indicating kidney damage, so mention supplementation to whoever orders your blood work.
Two honest limits. First, the very high single doses used in the sleep deprivation studies were given under medical supervision, and gastrointestinal side effects become more likely up there; those protocols are research settings, not instructions. Second, safety data in pregnancy, in adolescence outside supervised settings, and in people with existing kidney disease is thinner, and anyone in those categories, or on regular medication, should talk to a doctor before supplementing anything. That is not boilerplate. It is what the evidence actually supports saying.
What Would Change the Picture
I said at the top that this field is instructive, and part of what it teaches is what good evidence would look like when it arrives. Three things would move creatine brain benefits from early to established in my view.
A large, preregistered trial at brain relevant doses, something like 10 to 20 grams a day for several months, with brain imaging confirming that creatine levels actually rose, and cognitive outcomes chosen in advance. An independent replication of the Jülich sleep deprivation results from a different lab, ideally testing whether smaller repeated doses can do what one giant dose did. And properly powered trials in the two groups where the subgroup hints keep pointing, older adults and women, run by teams without a product to sell.
Several of these are reportedly in progress, which is the best thing that can be said about this literature right now: it is moving, and the newest studies are better designed than the old ones. A 2025 perspective in the Journal of Nutrition by Eckert, one of the researchers who caught the double counting problem, argued that public enthusiasm has been running well ahead of the data, with sales and social media engagement surging against a limited evidence base. He is right, and a creatine company telling you he is right is exactly the kind of thing this site was built to do. The mechanism is sound, the stressed brain findings are genuinely exciting, the safety record is excellent, and the everyday cognition claims are not yet earned. If you can hold all four of those thoughts at once, you understand creatine and the brain better than most of the internet.